Prostate Cell News 11.08 March 6, 2020 | |
| |
TOP STORYImpaired RhoU activity in fatty acid synthase depleted cells led to reduced adhesion turnover downstream of paxillin serine phosphorylation, which was rescued by addition of exogenous palmitate. [Oncogene] Full Article | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)Scientists report that exposure of PC3 metastatic prostate carcinoma cells to both reverse transcriptase inhibitors resulted in decreased proliferation and concomitantly induced genome damage, associated with rearrangements of the nuclear architecture. [Cancer Lett] Abstract Assays indicated that structural analogue AT2 was capable of effectively inhibiting the transcriptional function of androgen receptor (AR) and blocking the nuclear translocation of AR like the second-generation AR antagonists. [Eur J Med Chem] Abstract | Graphical Abstract Neutrophils Are Mediators of Metastatic Prostate Cancer Progression in Bone Bone marrow neutrophils directly induced apoptosis of prostate cancer in vitro and in vivo, such that neutrophil depletion in bone metastasis models enhanced bone metastatic prostate cancer growth. [Cancer Immunol Immunother] Full Article Androgen ablation combined with poly(ADP-ribose) glycohydrolase inhibition synergistically reduced base excision repair capacity in independently derived LNCaP and LAPC4 prostate cancer cell lines. [Sci Rep] Full Article Researchers studied the impact of estrogenic and anti-estrogenic ligands in well-studied in vitro prostate cancer models with appropriate controls, dosages, and estrogen receptor subtype-specific antibodies. [Sci Rep] Full Article Mutational and Transcriptomic Landscapes of a Rare Human Prostate Basal Cell Carcinoma The authors applied single-cell genomic amplification and RNA-Seq to a specimen of human prostate basal cell carcinoma. The transcription factor covariance network analysis showed that the basal cell carcinoma tumor cells had distinct regulatory networks. [Prostate] Abstract Investigators identified the specific N-terminal domain of retinoid acid-related orphan receptor α (RORα2) that enhanced prostate tumor progression and proliferation via lysine methylation-mediated recruitment of coactivator complex pontin/Tip60. [Int J Mol Sci] Full Article MIR-138-5P Inhibits the Progression of Prostate Cancer by Targeting FOXC1 Researchers showed MIR-138-5P expression level was significantly decreased in prostate cancer cell lines compared with the normal cell line. [Mol Genet Genomic Med] Full Article Scientists investigated the effects of lipopolysaccharide on proliferation, migration and invasion of prostate cancer cells and the protective effects of 1α,25(OH)2D3. [Int Immunopharmacol] Abstract Tomograms obtained by cryo-Soft X-ray Tomography of human PC3 prostate cancer cells were treated with organoiridium complex Ir[(C,N)2(O,O)], irradiated with blue light, and cryopreserved to maintain them in their native state. [J Biol Inorg Chem] Abstract Upregulation of PACE4 in Prostate Cancer Is Not Dependent on E2F Transcription Factors Investigators evaluated of E2Fs on PACE4 and PACE4 isoform expression in prostate cancer. They conducted in vitro molecular silencing studies in various prostate cancer cell lines and determined the change in PACE4 expression levels. [Can J Physiol Pharmacol] Abstract Subscribe to one of our other 19 science newsletters such as Mammary Cell News & ESC & iPSC News. | |
| |
REVIEWSKnowing What’s Growing: Why Ductal and Intraductal Prostate Cancer Matter Aggressive cancers often have distinctive pathologies, including intraductal carcinoma of the prostate and ductal adenocarcinoma. The authors review the importance of these pathologies, because they are often overlooked, especially in genomics and preclinical testing. [Sci Transl Med] Abstract The authors highlight the potential of metastasis-associated protein 1-targeted anticancer and antitumor effects of three dietary stilbenes, namely resveratrol, pterostilbene, and gnetin C, for prostate cancer management. [Semin Cancer Biol] Abstract Visit our reviews page to see a complete list of reviews in the prostate cell research field. | |
| |
INDUSTRY NEWSProscia and the University of California, San Francisco (UCSF) have partnered to introduce artificial intelligence into the practice of pathology. Beginning with prostate cancer, the collaboration will validate the clinical efficacy of computational pathology applications for several high-impact pathology subspecialties. [Proscia] Press Release Voluntis and Bristol-Myers Squibb to Co-Develop Digital Therapeutics for Oncology Voluntis announced a collaboration agreement to create and investigate digital therapeutic solutions that will support cancer patients. Leveraging Theraxium Oncology, Voluntis’ core platform for digital therapeutics in oncology, the collaboration will evaluate potential solutions that will support management of patient symptoms and remote monitoring by healthcare providers. [Voluntis] Press Release | |
| |
POLICY NEWSChina Bans Cash Rewards for Publishing Papers Chinese institutions have been told to stop paying researchers bonuses for publishing in journals, as part of a new national policy to cut perverse incentives that encourage scientists to publish lots of papers rather than focus on high-impact work. [Nature News] Editorial UC Santa Cruz Fires Graduate Students Taking Part in Strike The University of California, Santa Cruz, fired 54 graduate student employees from their teaching positions on February 28, in the latest escalation of a months-long dispute over student pay, the Santa Cruz Sentinel reports. [The Scientist] Editorial
| |
EVENTSNEW Cambridge International Stem Cell Symposium 2020 Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESNEW Postdoctoral Position – Prostate Cancer (University of Washington) Head – Single Cell Research (Sloan Kettering Institute) Senior Laboratory Research Scientist – Autophagy in Cancer (The Francis Crick Institute) Postdoctoral Studentship – Stress Signaling and Prostate Cancer (University of Oslo) Postdoctoral Fellow – Prostate Tumorigenesis (University of Cincinnati) Postdoctoral Fellow – RNA Splicing in Cancer (The University of Texas MD Anderson Cancer Center) Postdoctoral Position – Organoid Models of Prostate Cancer (University of Freiburg) Postdoctoral Position – Cancer Cell Competition (Albert Einstein College of Medicine) Postdoctoral Fellow – Cancer Biology (City of Hope) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in Prostate Cell News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|